Terrascent Stock Price, News & Analysis

TerrAscend Corp. (TSNDF) Stock Overview

TerrAscend Corp. (OTCQX: TSNDF) is a TSX-listed cannabis company with interests across the North American cannabis sector. According to the company’s disclosures, TerrAscend operates through TerrAscend Growth Corp. in several U.S. states and also has retail operations in Canada. Its activities span cultivation, processing, manufacturing and retail dispensaries serving both medical and legal adult-use cannabis markets.

TerrAscend’s common shares trade over-the-counter on the OTCQX Best Market under the symbol TSNDF, and the company identifies itself as a North American cannabis operator with a multi-state footprint. It reports that it has operations in U.S. states such as Pennsylvania, New Jersey, Maryland, Ohio, California and, in some periods, Michigan, alongside Canadian retail operations.

Business Model and Operations

Based on the company’s public descriptions, TerrAscend’s business model combines vertically integrated cannabis operations in key U.S. markets with branded retail chains and wholesale distribution. TerrAscend states that it operates The Apothecarium and other dispensary retail locations, as well as scaled cultivation, processing, and manufacturing facilities in its core markets. The company notes that its cultivation and manufacturing practices are intended to yield consistent, high-quality cannabis and an extensive product selection for medical and adult-use customers.

TerrAscend also highlights ownership or licensing of a portfolio of cannabis brands. Across its various press releases, the company lists brands and businesses such as The Apothecarium, Gage Cannabis, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. In some releases, Gage-branded retail locations are specifically mentioned, while in others the emphasis is on The Apothecarium and additional dispensary concepts.

Geographic Footprint and Market Focus

TerrAscend describes itself as having operations in multiple U.S. states and Canada. In several company communications, it notes operations in Pennsylvania, New Jersey, Maryland, Ohio, Michigan and California through TerrAscend Growth Corp., together with retail operations in Canada. In more recent descriptions, TerrAscend highlights operations in Pennsylvania, New Jersey, Maryland, Ohio and California and continues to reference Canadian retail operations.

The company has also disclosed a strategic review and exit plan for its Michigan operations. TerrAscend announced its intention to sell or divest all Michigan assets, including cultivation, processing facilities, and retail dispensaries, and to report the Michigan business as discontinued operations beginning with its second quarter 2025 financial results. Following completion of this exit plan, TerrAscend stated that it expects to operate dispensaries and cultivation and processing facilities across New Jersey, Maryland, Pennsylvania, Ohio, California and in Toronto, Ontario.

Retail and Dispensary Operations

TerrAscend’s public statements emphasize its retail presence under banners such as The Apothecarium and Gage, along with other dispensary retail locations. The company reports that it operates multiple dispensaries in New Jersey, Maryland and Pennsylvania, and has referenced additional locations in Ohio, California and Canada. In New Jersey, TerrAscend has highlighted Apothecarium stores and other dispensaries as key contributors to its retail performance, noting rankings among state dispensaries based on unit sales and revenue.

In a transaction-focused disclosure, TerrAscend described entering into and closing on an option agreement with Union Chill Cannabis Company LLC, a dispensary operator in Hunterdon County, New Jersey. Under that agreement, TerrAscend was granted an option to purchase a 35% equity interest in Union Chill, with consideration including convertible promissory notes and cash. The company has also stated in related press releases that the Union Chill transaction is expected to expand its New Jersey retail footprint.

Cultivation, Processing and Manufacturing

Across its news releases, TerrAscend states that it operates scaled cultivation, processing and manufacturing facilities in its core markets. The company has discussed expansions of cultivation capacity and manufacturing capabilities in states such as Maryland and New Jersey, and notes that these facilities support both its own branded products and, in some cases, licensed brands. TerrAscend describes its cultivation and manufacturing practices as focused on consistent quality and a broad product assortment for the markets it serves.

Brands and Licensed Partnerships

TerrAscend reports that it owns or licenses several synergistic cannabis businesses and brands. These include, in various company descriptions, Gage Cannabis, The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana and Valhalla Confections. In addition, the company has announced exclusive licensing agreements with third-party brands. For example, TerrAscend disclosed an exclusive licensing agreement with Tyson 2.0, the cannabis brand founded by Mike Tyson, to launch Tyson 2.0 products in Maryland and Pennsylvania, with manufacturing and distribution handled by TerrAscend and availability through Apothecarium stores and the company’s wholesale network.

Capital Structure, Financing and Share Repurchases

TerrAscend’s public filings and press releases describe several financing and capital allocation activities. The company has reported closing an upsized senior secured syndicated term loan, with proceeds used to retire existing indebtedness and the remainder designated for growth initiatives, including potential mergers and acquisitions. The loan is described as maturing in a future year and carrying a stated interest rate, with an additional uncommitted term loan facility available for strategic M&A.

TerrAscend has also announced a normal course issuer bid (NCIB) to repurchase a specified dollar amount of its common shares over a defined period. The company has disclosed the number of shares repurchased under a prior NCIB, along with the volume-weighted average purchase price and the proportion of the public float represented by the authorized repurchase amount. These disclosures indicate that TerrAscend uses share repurchases as one element of its capital allocation approach, subject to market conditions and regulatory limits.

Strategic Portfolio Management

In its communications, TerrAscend has described strategic actions to refine its portfolio of assets. The decision to exit the Michigan market, including the planned sale or divestiture of cultivation, processing and retail assets in that state, is presented as a move to focus on core markets and use net proceeds to pay down company debt. TerrAscend has also referenced acquisitions of dispensaries in other states, such as a dispensary in Ohio, as part of its approach to expanding in markets it identifies as core.

The company’s disclosures indicate that it evaluates markets based on competitive conditions, regulatory frameworks and its own performance, and that it may pursue acquisitions, divestitures and financing transactions to support its objectives in the North American cannabis sector.

Regulatory Environment and Risk Disclosure

TerrAscend’s press releases consistently include a section titled “Caution Regarding Cannabis Operations in the United States.” In this section, the company notes that cannabis remains a Schedule I drug under the U.S. Controlled Substances Act, and that it is illegal under U.S. federal law to cultivate, distribute or possess cannabis, among other activities. TerrAscend further notes that financial transactions involving proceeds from cannabis-related business activities may be subject to U.S. federal money laundering laws.

The company states that, although federal enforcement has trended toward non-enforcement against businesses that comply with state medical or adult-use cannabis programs, compliance with state law does not eliminate federal legal risk. TerrAscend identifies the enforcement of federal laws in the United States as a significant risk to its business and notes that proceedings under these laws could adversely affect its operations and financial performance. The company also refers readers to risk factor discussions in its Management’s Discussion and Analysis (MD&A) and Annual Report filed with Canadian securities regulators and the U.S. Securities and Exchange Commission.

Use of U.S. GAAP and Reporting

TerrAscend states that it prepares its financial statements in accordance with U.S. Generally Accepted Accounting Principles (GAAP), and that it reports certain non-GAAP measures, such as EBITDA from continuing operations, Adjusted EBITDA from continuing operations, Adjusted EBITDA margin from continuing operations and Free Cash Flow. The company explains that its Michigan operations are reported as discontinued operations beginning with its second quarter 2025 financial results, reflecting its intention to exit that market.

In its Form 8-K filings with the SEC, TerrAscend furnishes press releases announcing quarterly financial results and business highlights. These filings identify the company as a Canadian issuer with a Commission File Number and note that its common shares trade on the OTCQX Best Market under the symbol TSNDF.

Union Chill Transaction and Convertible Notes

TerrAscend’s Form 8-K dated December 30, 2025 describes an option agreement with Union Chill Cannabis Company LLC, a dispensary operator in Hunterdon County, New Jersey. The company reports that it closed on the option agreement and was granted an option to purchase a 35% equity interest in Union Chill. In connection with this transaction, TerrAscend issued convertible promissory notes to the sellers in an aggregate principal amount of $9,000,000 and agreed to pay an additional $4,000,000 in cash upon exercise of the option, for total consideration of $13,000,000.

The notes accrue interest at a stated annual rate, are payable quarterly, and mature on a specified future date. Prior to maturity, each note may be converted, in its entirety, into common shares of TerrAscend at a defined conversion price. The company states that the notes and any shares issuable upon conversion were offered and sold in reliance on an exemption from registration under the U.S. Securities Act of 1933.

Position in the Cannabis Sector

In multiple press releases, TerrAscend refers to itself as a leading TSX-listed cannabis company with interests across the North American cannabis sector. It emphasizes its presence in several U.S. states and Canada, its vertically integrated operations in certain markets, its branded retail chains and its portfolio of owned and licensed cannabis brands. The company’s disclosures portray a business focused on cultivation, processing, manufacturing and retail distribution of cannabis products within the regulatory frameworks of the jurisdictions in which it operates, while acknowledging the overarching federal legal risks in the United States.